Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer
Clinical trial NCT00114816 · COMPLETED
Trial details
- NCT number
- NCT00114816
- Sponsor
- Finnish Breast Cancer Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.